Company: LENZ
Filing Date: 2025-07-30
Form Type: 10-Q
Source: 0001815776-25-000056
Chunk: 358

Company: LENZ Therapeutics, Inc.
Filing Date: 2025-07-30
Form: 10-Q
Item: Part I, Item 8
Chunk 358
---
-backed securities2,012 — 2,012 — Total marketable securities measured at fair value$171,911 $51,902 $120,009 $— At December 31, 2024:Cash equivalentsMoney market funds$17,693 $17,693 $— $— U.S. government securities999 — 999 — U.S. treasury securities997 997 — — Total cash equivalents measured at fair value$19,689 $18,690 $999 $— Marketable securitiesCommercial paper$58,823 $— $58,823 $— U.S. treasury securities46,309 46,309 — — Corporate debt securities43,669 — 43,669 — U.S. government agency securities40,071 — 40,071 — Total marketable securities measured at fair value$188,872 $46,309 $142,563 $— 

15

The following table presents the amortized cost and estimated fair market value of our cash equivalents and marketable securities as of the dates presented (in thousands):June 30, 2025Amortized CostGrossUnrealizedGainsGrossUnrealizedLossesEstimated FairValueCash equivalents:Money market funds$35,609 $— $— $35,609 Corporate debt securities1,550 — — 1,550 Marketable securities:U.S. treasury securities$51,865 $42 $(5)$51,902 Commercial paper50,563 5 (20)50,548 Corporate debt securities48,992 17 (4)49,005 U.S. government agency securities18,440 8 (4)18,444 Asset-backed securities2,013 — (1)2,012 Totals$209,032 $72 $(34)$209,070 December 31, 2024Amortized CostGrossUnrealizedGainsGrossUnrealizedLossesEstimated FairValueCash equivalents:Money market funds$17,693 $— $— $17,693 U.S. government securities999 — — 999 U.S. treasury securities997 — — 997 Marketable securities:Commercial paper$58,798 $56 $(